07:00 , Oct 24, 2013 |  BC Innovations  |  Cover Story

A platform for RNA

An information explosion on the number of functional RNA molecules expressed in cells and the mechanisms by which they control gene expression 1,2 is driving the formation and funding of biotechs developing oligonucleotide-based therapeutics. Pharmas...
08:00 , Dec 5, 2011 |  BC Week In Review  |  Company News

Axolabs, Roche deal

The management of Roche's Roche Center for Excellence for RNA Therapeutics completed the acquisition of the center, and renamed the resulting newco Axolabs. Axolabs will provide nucleic acid drug discovery and preclinical R&D services. Axolabs...